Literature DB >> 21393199

Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.

Jane Freeman, Simon D Baines, Sharie L Todhunter, Grace S Huscroft, Mark H Wilcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21393199     DOI： 10.1093/jac/dkr077

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Action of nitroheterocyclic drugs against Clostridium difficile.

Authors:  Manish Kumar; Sudip Adhikari; Julian G Hurdle
Journal:  Int J Antimicrob Agents       Date:  2014-07-25       Impact factor: 5.283

Review 2.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

3.  Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea.

Authors:  Yoav Golan; Lauren Epstein
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

Review 4.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

Review 5.  A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection.

Authors:  Csaba Fehér; Alex Soriano; Josep Mensa
Journal:  Infect Dis Ther       Date:  2016-12-01

Review 6.  Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.

Authors:  Lissa S Tsutsumi; Yaw B Owusu; Julian G Hurdle; Dianqing Sun
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

Review 7.  Nitazoxanide: a first-in-class broad-spectrum antiviral agent.

Authors:  Jean-François Rossignol
Journal:  Antiviral Res       Date:  2014-08-07       Impact factor: 5.970

8.  Antimicrobial susceptibility of Brazilian Clostridium difficile strains determined by agar dilution and disk diffusion.

Authors:  Edmir Geraldo Fraga; Antonio Carlos Nicodemo; Jorge Luiz Mello Sampaio
Journal:  Braz J Infect Dis       Date:  2016-08-16       Impact factor: 3.257
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.